Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Patrick Amstutz
Michael Tobias Stumpp
Alexander Zürcher
Laura Jeanbart
Michael Pitzner
Ph.D. Daniel Steiner
Philippe Legenne
Renate Gloggner
Robert Hendriks
Seth Lewis
Board:
Agnete Brunsvik Fredriksen
Dominik Höchli
Michael Vasconcelles
Steven Holtzman
Vito Palombella
Sandipkumar S. Kapadia
William Burns
Shareholding in %:
BVF Partners LP 21.14
GAM Investment Management (Switzerland) AG 2.45
Michael Tobias Stumpp 1.77
Molecular Partners AG 8.67
Novartis AG 4.31
Patrick Amstutz 1.85
Pictet Asset Management SA 0.23
UBS Asset Management Switzerland AG 4.99
Zenito Oy 0.31
Zürcher Kantonalbank (Investment Management) 0.81
Freefloat 53.47
Address: Wagistrasse 14, 8952 Schlieren
T: +41-44-755-77-00
F: +
I: http://www.molecularpartners.com
E: info@molecularpartners.com